Table 3. Estimated total treatment costs (£2002).

	Capecitabine	UFT/LV	Mayo	MdG (outpatient)	de Gramont (in-patient)
Drug cost	464	892	189	394	563
Administration	113	64	839	650	1500
Adverse events	131	170	170	29	22
Total 28-day costs	708	1126	1126	1073	2085
One-off costs	7	7	0	265	0
Total treatment costs (based on 12 week period)	2132	3385	3593	3485	6255
Cost savings on capecitabine			−1461	−1353	−4123
Cost savings on UFT/LV			−209	−101	−2870